
कृपया अन्य खोज का प्रयास करें
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
A. Michael Lincoff | - | 2005 | Member of Scientific Advisory Board |
Jeffrey Weitz | - | - | Member of Scientific Advisory Board |
Paul W. Armstrong | - | - | Chairman of Scientific Advisory Board |
Pierre Theroux | - | - | Member of Scientific Advisory Board |
Stephen Hanessian | - | - | Member of Scientific Advisory Board |
Brent Fawkes | 54 | 2013 | Independent Director |
Arnold Naimark | 90 | 2000 | Independent Director |
James F. Kinley | 46 | 2011 | Director |
Albert David Friesen | 77 | 1997 | Founder, CEO & Chairman of the board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है